mRNA Vaccines Enhance Neutralizing Immunity against SARS-CoV-2 Variants in Convalescent and ChAdOx1-Primed Subjects.
Fabricius D, Ludwig C, Scholz J, Rode I, Tsamadou C, Jacobsen EM, Winkelmann M, Grempels A, Lotfi R, Janda A, Körper S, Adler G, Debatin KM, Schrezenmeier H, Jahrsdörfer B.
Fabricius D, et al. Among authors: grempels a.
Vaccines (Basel). 2021 Aug 18;9(8):918. doi: 10.3390/vaccines9080918.
Vaccines (Basel). 2021.
PMID: 34452043
Free PMC article.